Stanley Abel

Mr. Stanley E.
Abel is an Independent Director at Adynxx, Inc. and a President, Chief Executive Officer & Director at ProJenX, Inc. He is on the Board of Directors at Adynxx, Inc. and ProJenX, Inc. Mr. Abel was previously employed as a Chairman by Biotechnology Innovation Organization, a Chairman by SiteOne Therapeutics, Inc., a Chief Business Officer by Sonexa Therapeutics, Inc., a Chief Executive Officer by Corthera, Inc., a Chief Financial Officer by Cerexa, Inc., a Chief Financial Officer by Peninsula Pharmaceuticals, Inc., a Principal by Eli Lilly & Co., and a Chairman & President by The Montana Bioscience Alliance.
He also served on the board at Adynxx, Inc. (Old).
He received his undergraduate degree from Indiana University and an MBA from The University of Chicago.